US Patent Issued to Visterra on Sept. 16 for "Antibody molecules to C5AR1 and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,865, issued on Sept. 16, was assigned to Visterra Inc. (Waltham, Mass.).

"Antibody molecules to C5AR1 and uses thereof" was invented by Karthik Viswanathan (Waltham, Mass.), Brian Booth (Waltham, Mass.), Boopathy Ramakrishnan (Waltham, Mass.), Andrew Wollacott (Waltham, Mass.), Gregory Babcock (Waltham, Mass.) and Zachary Shriver (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antibody molecules that specifically bind to C5aR1 are disclosed. The antibody molecules can be used to treat, prevent, and/or diagnose disorders, such as ANCA-vasculitis."

The patent was filed on Sept. 29, 2023, under Application No. 18/478,846.

*For further...